156 related articles for article (PubMed ID: 35268282)
1. The Impact of SARS-CoV-2 Primary Vaccination in a Cohort of Patients Hospitalized for Acute COVID-19 during Delta Variant Predominance.
Stupica D; Collinet-Adler S; Kejžar N; Jagodic Z; Poljak M; Nahtigal Klevišar M
J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268282
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Vaccination and Clinical Presentation of COVID-19 in Patients Hospitalized during the Delta- and Omicron-Predominant Periods.
Stupica D; Collinet-Adler S; Kejžar N; Poljak M; Štamol T
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769609
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
[TBL] [Abstract][Full Text] [Related]
5. Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study.
Robalo Q; De Mot L; Vandromme M; Van Goethem N; Gabrio A; Chung PYJ; Meurisse M; Belgian Collaborative Group On Covid-Hospital Surveillance ; Catteau L; Thijs C; Blot K
Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679859
[TBL] [Abstract][Full Text] [Related]
6. Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.
Taylor CA; Patel K; Pham H; Whitaker M; Anglin O; Kambhampati AK; Milucky J; Chai SJ; Kirley PD; Alden NB; Armistead I; Meek J; Yousey-Hindes K; Anderson EJ; Openo KP; Teno K; Weigel A; Monroe ML; Ryan PA; Henderson J; Nunez VT; Bye E; Lynfield R; Poblete M; Smelser C; Barney GR; Spina NL; Bennett NM; Popham K; Billing LM; Shiltz E; Abdullah N; Sutton M; Schaffner W; Talbot HK; Ortega J; Price A; Garg S; Havers FP;
MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(43):1513-1519. PubMed ID: 34710076
[TBL] [Abstract][Full Text] [Related]
7. Association of disease severity and death outcome with vaccination status of admitted COVID-19 patients in delta period of SARS-COV-2 in mixed variety of vaccine background.
Aslam J; Rauf Ul Hassan M; Fatima Q; Bashir Hashmi H; Alshahrani MY; Alkhathami AG; Aneela I
Saudi J Biol Sci; 2022 Jul; 29(7):103329. PubMed ID: 35668728
[TBL] [Abstract][Full Text] [Related]
8. Decreased severity of COVID-19 in vaccinated pregnant individuals during predominance of different SARS-CoV-2 variants.
Eid J; Abdelwahab M; Williams H; Caplan M; Hajmurad S; Venkatesh KK; Costantine MM; Rood KM
Am J Reprod Immunol; 2022 Sep; 88(3):e13596. PubMed ID: 35789021
[TBL] [Abstract][Full Text] [Related]
9. An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward.
Wi YM; Kim SH; Peck KR
J Korean Med Sci; 2022 Jan; 37(4):e28. PubMed ID: 35075827
[TBL] [Abstract][Full Text] [Related]
10. Adults hospitalized with breakthrough COVID-19 have lower mortality than matched unvaccinated adults.
Myers LC; Kipnis P; Greene J; Lawson B; Escobar GJ; Fireman BH; Klein NP; Liu VX
J Intern Med; 2022 Aug; 292(2):377-384. PubMed ID: 35531712
[TBL] [Abstract][Full Text] [Related]
11. Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination.
Butt AA; Nafady-Hego H; Chemaitelly H; Abou-Samra AB; Khal AA; Coyle PV; Kanaani ZA; Kaleeckal AH; Latif AN; Masalmani YA; Bertollini R; Raddad LJA
Int J Infect Dis; 2021 Sep; 110():353-358. PubMed ID: 34375762
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence.
Puranik A; Lenehan PJ; Silvert E; Niesen MJM; Corchado-Garcia J; O'Horo JC; Virk A; Swift MD; Halamka J; Badley AD; Venkatakrishnan AJ; Soundararajan V
medRxiv; 2021 Aug; ():. PubMed ID: 34401884
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
Lopez Bernal J; Andrews N; Gower C; Robertson C; Stowe J; Tessier E; Simmons R; Cottrell S; Roberts R; O'Doherty M; Brown K; Cameron C; Stockton D; McMenamin J; Ramsay M
BMJ; 2021 May; 373():n1088. PubMed ID: 33985964
[TBL] [Abstract][Full Text] [Related]
14. Hospitalised patients with breakthrough COVID-19 following vaccination during two distinct waves in Israel, January to August 2021: a multicentre comparative cohort study.
Brosh-Nissimov T; Maor Y; Elbaz M; Lipman-Arens S; Wiener-Well Y; Hussein K; Orenbuch-Harroch E; Cohen R; Zimhony O; Chazan B; Nesher L; Rahav G; Zayyad H; Hershman-Sarafov M; Weinberger M; Najjar-Debbiny R; Chowers M
Euro Surveill; 2022 May; 27(20):. PubMed ID: 35593161
[TBL] [Abstract][Full Text] [Related]
15. Breakthrough COVID-19 Infection During the Delta Variant Dominant Period: Individualized Care Based on Vaccination Status Is Needed.
Lee CM; Lee E; Park WB; Choe PG; Song KH; Kim ES; Park SW
J Korean Med Sci; 2022 Aug; 37(32):e252. PubMed ID: 35971766
[TBL] [Abstract][Full Text] [Related]
16. Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland.
Rzymski P; Pazgan-Simon M; Kamerys J; Moniuszko-Malinowska A; Sikorska K; Wernik J; Zarębska-Michaluk D; Supronowicz Ł; Sobala-Szczygieł B; Skrzat-Klapaczyńska A; Simon K; Piekarska A; Czupryna P; Pawłowska M; Brzdęk M; Jaroszewicz J; Kowalska J; Renke M; Flisiak R
Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455306
[TBL] [Abstract][Full Text] [Related]
17. Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort study.
Bahl A; Johnson S; Maine G; Garcia MH; Nimmagadda S; Qu L; Chen NW
Lancet Reg Health Am; 2021 Dec; 4():100065. PubMed ID: 34522911
[TBL] [Abstract][Full Text] [Related]
18. Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged ≥12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021.
Naleway AL; Groom HC; Crawford PM; Salas SB; Henninger ML; Donald JL; Smith N; Thompson MG; Blanton LH; Bozio CH; Azziz-Baumgartner E
MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(46):1608-1612. PubMed ID: 34793417
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and respiratory care in hospitalized vaccinated SARS-CoV-2 patients.
Teran-Tinedo JR; Gonzalez-Rubio J; Najera A; Castany-Faro A; Contreras MLN; Garcia IM; Lopez-Mellado L; Lorente-Gonzalez M; Perez-Garvin P; Sacristan-Crespo G; Suarez-Ortiz M; Navarro-Lopez JD; Jimenez-Diaz L; Landete P
EClinicalMedicine; 2022 Jun; 48():101453. PubMed ID: 35611064
[TBL] [Abstract][Full Text] [Related]
20. Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
Bozio CH; Grannis SJ; Naleway AL; Ong TC; Butterfield KA; DeSilva MB; Natarajan K; Yang DH; Rao S; Klein NP; Irving SA; Dixon BE; Dascomb K; Liao IC; Reynolds S; McEvoy C; Han J; Reese SE; Lewis N; Fadel WF; Grisel N; Murthy K; Ferdinands J; Kharbanda AB; Mitchell PK; Goddard K; Embi PJ; Arndorfer J; Raiyani C; Patel P; Rowley EA; Fireman B; Valvi NR; Griggs EP; Levy ME; Zerbo O; Porter RM; Birch RJ; Blanton L; Ball SW; Steffens A; Olson N; Williams J; Dickerson M; McMorrow M; Schrag SJ; Verani JR; Fry AM; Azziz-Baumgartner E; Barron M; Gaglani M; Thompson MG; Stenehjem E
MMWR Morb Mortal Wkly Rep; 2021 Nov; 70(44):1539-1544. PubMed ID: 34735425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
